News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Visterra, Inc. Presents Prophylactic and Therapeutic Efficacy Data of VIS410 Against the H5N1 (Avian Flu) Influenza Strain in Hanoi, Viet Nam


10/29/2012 6:57:38 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., developer of novel medicines to prevent and treat infectious and other major diseases, today announced that its Chief Medical Officer, Donna Ambrosino, MD, has been invited by the International Society for Influenza and Other Respiratory Virus Diseases (isirv) to present VIS410 at its Antiviral Group (isirv-AVG) Conference entitled “Severe Influenza: Burden, Pathogenesis and Management” being held in Hanoi, Viet Nam on October 29-31, 2012. The isirv-AVG is an independent and international scientific professional society which has lead responsibility for organizing the largest international conference exclusively devoted to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness.

Read at BioSpace.com

comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES